Canada markets closed

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.9200+0.1900 (+10.98%)
At close: 04:00PM EDT
2.0500 +0.13 (+6.77%)
After hours: 07:57PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-27,029
-27,029
-41,307
-43,241
-5,995
Depreciation & amortization
151
151
367
460
632
Stock based compensation
2,147
2,147
2,692
4,232
5,747
Change in working capital
-3,594
-3,594
1,412
-3,236
1,909
Accounts receivable
562
562
-81
-507
0
Accounts Payable
-451
-451
411
-1,902
1,019
Other working capital
-23,969
-23,969
-27,292
-36,720
-34,854
Net cash provided by operating activites
-23,935
-23,935
-27,023
-36,715
-34,778
Cash flows from investing activities
Investments in property, plant and equipment
-34
-34
-269
-5
-76
Purchases of investments
-47,048
-47,048
-66,191
-9,357
-42,540
Sales/Maturities of investments
62,623
62,623
43,162
30,922
87,385
Net cash used for investing activites
15,541
15,541
-23,276
21,560
44,769
Cash flows from financing activities
Common stock issued
7,843
7,843
0
60,943
1,222
Net cash used privided by (used for) financing activities
7,855
7,855
0
62,158
1,310
Net change in cash
-539
-539
-50,299
47,003
11,301
Cash at beginning of period
13,159
13,159
63,458
16,455
5,154
Cash at end of period
12,620
12,620
13,159
63,458
16,455
Free Cash Flow
Operating Cash Flow
-23,935
-23,935
-27,023
-36,715
-34,778
Capital Expenditure
-34
-34
-269
-5
-76
Free Cash Flow
-23,969
-23,969
-27,292
-36,720
-34,854